Nichols Elizabeth, O'Hara Nathan N, Degani Yasmin, Sprague Sheila A, Adachi Jonathan D, Bhandari Mohit, Holick Michael F, Connelly Daniel W, Slobogean Gerard P
Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD.
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
BMJ Open. 2018 Apr 12;8(4):e019685. doi: 10.1136/bmjopen-2017-019685.
Vitamin D is often prescribed as an adjuvant therapy to aid fracture healing due to its biological role in bone health. However, the optimal frequency, dosage and duration of vitamin D supplementation for non-osteoporotic fracture healing has not been established. The objective of this study was to determine patient preferences for fracture healing relative to hypothetical vitamin D supplementation dosing options.
Discrete choice experiment.
Level 1 trauma centre in Baltimore, Maryland, USA.
199 adult (18-60 years) patients with a fracture.
Parameter estimates of utility for fracture healing relative to dosing regimens were analysed using hierarchical Bayesian modelling.
A reduced risk of reoperation (34.3%) and reduced healing time (24.4%) were the attributes of greatest relative importance. The highest mean utility estimates were for a one-time supplementation dose (ß=0.71, 95% CI 0.41 to 1.00) followed by a reduced risk of reoperation (ß=0.41 per absolute % reduction, 95% CI 0.0.36 to 0.46). Supplementation for 24 weeks in duration (ß=-0.83, 95% CI -1.00 to -0.67) and a daily supplement (ß=-0.29, 95% CI -0.47 to -0.11) had the lowest mean utilities. The 'no supplement' option had a large negative value suggesting supplementation was generally desirable in this sample population. Among other possible clinical scenarios, patients expected a 2% reduction in the absolute risk of reoperation or a 3.1-week reduction in healing time from the baseline to accept a treatment regimen requiring two separate doses of supplementation, two blood tests and a cost of $20 within 3 months of injury.
Patients with orthopaedic trauma demonstrated strong willingness to take a vitamin D supplement that would decrease risk of reoperation and reduce healing time. Furthermore, these findings specify the required decrease in reoperation risk and reduction in healing time patients would expect to adhere to possible vitamin D dosing regimens.
维生素D因其在骨骼健康中的生物学作用,常被用作辅助治疗以促进骨折愈合。然而,对于非骨质疏松性骨折愈合,维生素D补充的最佳频率、剂量和持续时间尚未确定。本研究的目的是确定相对于假设的维生素D补充给药方案,患者对骨折愈合的偏好。
离散选择实验。
美国马里兰州巴尔的摩的一级创伤中心。
199名成年(18 - 60岁)骨折患者。
使用分层贝叶斯模型分析相对于给药方案的骨折愈合效用参数估计值。
再次手术风险降低(34.3%)和愈合时间缩短(24.4%)是相对重要性最高的属性。平均效用估计值最高的是一次性补充剂量(β = 0.71,95%可信区间0.41至1.00),其次是再次手术风险降低(每绝对降低1%,β = 0.41,95%可信区间0.36至0.46)。持续补充24周(β = -0.83,95%可信区间 -1.00至 -0.67)和每日补充(β = -0.29,95%可信区间 -0.47至 -0.11)的平均效用最低。“不补充”选项具有很大的负值,表明在该样本人群中通常希望进行补充。在其他可能的临床情况中,患者期望从基线起再次手术的绝对风险降低2%或愈合时间缩短3.1周,以接受一种在受伤后3个月内需要两次单独补充剂量、两次血液检查且费用为20美元的治疗方案。
骨科创伤患者表现出强烈意愿服用可降低再次手术风险和缩短愈合时间的维生素D补充剂。此外,这些发现明确了患者为坚持可能的维生素D给药方案而期望的再次手术风险降低幅度和愈合时间缩短幅度。